4.7 Article

KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

Ewing's Sarcoma

Nicolo Riggi et al.

Summary: Ewing's sarcoma is an aggressive cancer that primarily affects children and young adults. In 85 to 90% of cases, a t(11;22) translocation is present. Treatment typically involves surgery, radiotherapy, and chemotherapy, with a 5-year survival rate of around 70%.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Oncology

Recent insight into the role of FBXW7 as a tumor suppressor

Kanae Yumimoto et al.

SEMINARS IN CANCER BIOLOGY (2020)

Review Biotechnology & Applied Microbiology

Management of recurrent Ewing sarcoma: challenges and approaches

David Van Mater et al.

ONCOTARGETS AND THERAPY (2019)

Review Chemistry, Medicinal

Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target

Yi-Chao Zheng et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Medicine, General & Internal

Ewing sarcoma

Thomas G. P. Gruenewald et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Review Biochemistry & Molecular Biology

FBXW7: a critical tumor suppressor of human cancers

Chien-Hung Yeh et al.

MOLECULAR CANCER (2018)

Review Genetics & Heredity

Epigenetic modulators, modifiers and mediators in cancer aetiology and progression

Andrew P. Feinberg et al.

NATURE REVIEWS GENETICS (2016)

Review Genetics & Heredity

Targeting the cancer epigenome for therapy

Peter A. Jones et al.

NATURE REVIEWS GENETICS (2016)

Review Pharmacology & Pharmacy

Jumonji histone demethylases as emerging therapeutic targets

Sung Yeon Park et al.

PHARMACOLOGICAL RESEARCH (2016)

Review Genetics & Heredity

The roles of Jumonji-type oxygenases in human disease

Catrine Johansson et al.

EPIGENOMICS (2014)

Article Biochemistry & Molecular Biology

Extended Self-Renewal and Accelerated Reprogramming in the Absence of Kdm5b

Benjamin L. Kidder et al.

MOLECULAR AND CELLULAR BIOLOGY (2013)

Article Multidisciplinary Sciences

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Michael S. Lawrence et al.

NATURE (2013)

Review Biotechnology & Applied Microbiology

Histone lysine demethylases as targets for anticancer therapy

Jonas W. Hojfeldt et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Review Multidisciplinary Sciences

Epigenetic Reprogramming in Cancer

Mario L. Suva et al.

SCIENCE (2013)

Article Cell Biology

An integrated view of cyclin E function and regulation

Ka Tat Siu et al.

CELL CYCLE (2012)

Article Oncology

Epigenetic Changes in Pediatric Solid Tumors: Promising New Targets

Elizabeth R. Lawlor et al.

CLINICAL CANCER RESEARCH (2012)

Article Biochemistry & Molecular Biology

Jarid1b targets genes regulating development and is involved in neural differentiation

Sandra U. Schmitz et al.

EMBO JOURNAL (2011)

Article Oncology

Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

Ruth Ladenstein et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Multidisciplinary Sciences

EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation

Guenther H. S. Richter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Oncology

The biology of Ewing sarcoma

Nicolo Riggi et al.

CANCER LETTERS (2007)

Review Biochemistry & Molecular Biology

Dynamic regulation of histone lysine methylation by demethylases

Yang Shi et al.

MOLECULAR CELL (2007)

Article Multidisciplinary Sciences

Ras activity regulates cyclin E degradation by the Fbw7 pathway

AC Minella et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Oncology

Cyclin E overexpression and amplification in human tumours

P Schraml et al.

JOURNAL OF PATHOLOGY (2003)

Article Multidisciplinary Sciences

Proliferation, cell cycle and apoptosis in cancer

GI Evan et al.

NATURE (2001)